A signed readout of organelle dynamics — biogenesis minus selective clearance — from ordinary expression data. Predicts mitochondrial drug and genetic vulnerability across 1,066 cancer cell lines.
-
Updated
Aug 14, 2026 - HTML
A signed readout of organelle dynamics — biogenesis minus selective clearance — from ordinary expression data. Predicts mitochondrial drug and genetic vulnerability across 1,066 cancer cell lines.
Capacity Bio — independent third-party profile of a public API surface, by API Evangelist. Capacity Bio is a clinical-stage biotechnology company developing mitophagy therapeutics to restore mitochondrial quality control in age- and disease-related conditions. Its platform advances small molecules, peptides, and nanoparticles that enhance identific
To associate your repository with the mitophagy topic, visit your repo's landing page and select "manage topics."